NASER W AZAR

Allopathic & Osteopathic Physicians|Family Medicine CORONA, CA NPI 1700956331

General Payments — all program years on this page

$3,545.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 204
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $327.63 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $327.6317

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $96.055
Novo Nordisk AS $71.674
Acerta Pharma LLC $35.922
PFIZER INC. $32.762
ABBVIE INC. $31.621
Phadia US Inc. $22.291
GlaxoSmithKline, LLC. $21.931
Exact Sciences Corporation $15.391

By program year

Program yearAmountRecords
2018 $456.0025
2019 $306.1921
2020 $294.8917
2021 $457.0729
2022 $711.8339
2023 $991.9056
2024 $327.6317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067584134 Phadia US Inc. $22.29 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096846318 Novo Nordisk Inc $18.48 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096892925 Novo Nordisk Inc $19.28 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097303513 Novo Nordisk Inc $18.17 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097542959 Novo Nordisk Inc $15.74 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103257135 ABBVIE INC. $31.62 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104786372 AstraZeneca Pharmaceuticals LP $19.51 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105378218 AstraZeneca Pharmaceuticals LP $16.41 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116347758 GlaxoSmithKline, LLC. $21.93 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125822385 Exact Sciences Corporation $15.39 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132008144 PFIZER INC. $17.86 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132014738 PFIZER INC. $14.90 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135233771 Lilly USA, LLC $24.87 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135235436 Lilly USA, LLC $13.08 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135236089 Lilly USA, LLC $25.62 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135269479 Lilly USA, LLC $16.92 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135269483 Lilly USA, LLC $15.56 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.